Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis

被引：1

作者：

Weinbergerova, Barbora ^{[1
,2
]}

Mayer, Jiri ^{[1
,2
]}

Kabut, Tomas ^{[1
,2
]}

Sperr, Wolfgang R. ^{[3
,4
]}

Stevkova, Jana ^{[5
]}

Jonasova, Anna ^{[6
]}

Cernan, Martin ^{[7
,8
]}

Herndlhofer, Susanne ^{[3
]}

Oravcova, Iveta ^{[9
,10
]}

Sramek, Jiri ^{[11
]}

Novak, Jan ^{[12
,13
]}

Stepanova, Radka ^{[14
]}

Szotkowski, Tomas ^{[7
,8
]}

Drgona, Lubos ^{[9
,10
]}

Zak, Pavel ^{[5
]}

Valent, Peter ^{[3
,4
]}

机构：

[1] Masaryk Univ, Dept Internal Med Hematol & Oncol, Jihlavska 20, Brno 62500, Czech Republic

[2] Univ Hosp Brno, Jihlavska 20, Brno 62500, Czech Republic

[3] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria

[4] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria

[5] Univ Hosp Hradec Kralove, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic

[6] Charles Univ Prague, Gen Hosp, Med Dept, Hematol, Prague, Czech Republic

[7] Palacky Univ Olomouc, Fac Med & Dent, Dept Hemato Oncol, Olomouc, Czech Republic

[8] Univ Hosp Olomouc, Olomouc, Czech Republic

[9] Comenius Univ, Dept Oncohematol, Bratislava, Slovakia

[10] Natl Canc Inst, Bratislava, Slovakia

[11] Univ Hosp Plzen, Dept Haematol & Oncol, Plzen, Czech Republic

[12] Charles Univ Prague, Fac Med 3, Dept Haematol, Prague, Czech Republic

[13] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[14] Masaryk Univ, Fac Med, Ctr Excellence CREAT, Brno, Czech Republic

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 205卷 / 05期

关键词：

acute myeloid leukaemia; antifungal prophylaxis; fungal infection; venetoclax and azacitidine;

D O I：

10.1111/bjh.19670

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Our observational study analysed fungal infection frequency within cohorts with versus without antifungal prophylaxis (AFP) among newly diagnosed first-line venetoclax and azacitidine (VEN + AZA)-treated acute myeloid leukaemias in Czech, Austrian and Slovak haematology centres. Among 186 patients, 85 (46%) received antifungal prophylaxis, while 101 (54%) received no prophylaxis. Fungal infections occurred in 1/85 patients with prophylaxis (1%) and 5/101 patients without prophylaxis (5%) (p = 0.222). No significant difference was recorded between cohorts with and without AFP in terms of death rate (p = 0.296) and overall survival (p = 0.844). In conclusion, most infections were not severe, developing during the first treatment-cycle and did not affect patients' overall outcome.

引用

页码：1746 / 1750

页数：5

共 12 条

[1] Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
Aldoss, Ibrahim
Dadwal, Sanjeet
Zhang, Jianying
Tegtmeier, Bernard
Mei, Matthew
Arslan, Shukaib
Al Malki, Monzr M.
Salhotra, Amandeep
Ali, Haris
Aribi, Ahmed
Sandhu, Karamjeet
Khaled, Samer
Snyder, David
Nakamura, Ryotaro
Stein, Anthony S.
Forman, Stephen J.
Marcucci, Guido
Pullarkat, Vinod
[J]. BLOOD ADVANCES, 2019, 3 (23) : 4043 - 4049
[2] Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax
Chen, Evan C.
Liu, Yiwen
Harris, Courtney E.
Winer, Eric S.
Wadleigh, Martha
Lane, Andrew A.
Vedula, Rahul S.
Lindsley, R. Coleman
Copson, Kevin M.
Charles, Anne
Marty, Francisco
Neuberg, Donna
DeAngelo, Daniel J.
Stone, Richard M.
Luskin, Marlise R.
Issa, Nicolas C.
Garcia, Jacqueline S.
[J]. LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1934 - 1941
[3] Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study
De la Garza-Salazar, Fernando
Colunga-Pedraza, Perla Rocio
Gomez-Almaguer, David
Garcia-Zarate, Valeria Abigail
Gomez-De Leon, Andres
[J]. LEUKEMIA RESEARCH, 2023, 133
[4] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
DiNardo, C. D.
Jonas, B. A.
Pullarkat, V.
Thirman, M. J.
Garcia, J. S.
Wei, A. H.
Konopleva, M.
Doehner, H.
Letai, A.
Fenaux, P.
Koller, E.
Havelange, V.
Leber, B.
Esteve, J.
Wang, J.
Pejsa, V.
Hajek, R.
Porkka, K.
Illes, A.
Lavie, D.
Lemoli, R. M.
Yamamoto, K.
Yoon, S. -S.
Jang, J. -H.
Yeh, S. -P.
Turgut, M.
Hong, W. -J.
Zhou, Y.
Potluri, J.
Pratz, K. W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
[5] Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
Hall, Victoria G.
Tang, Kenny
Kumar, Deepali
Rotstein, Coleman
Chow, Signy
Chan, Steven M.
Husain, Shahid
Hosseini-Moghaddam, Seyed M.
[J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (03):
[6] Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study
Jonas, Brian A.
DiNardo, Courtney
Fracchiolla, Nicola
Pristupa, Alexander
Ishizawa, Kenichi
Jin, Jie
Konopleva, Marina
Ofran, Yishai
Montesinos, Pau
Kovacsovics, Tibor
Jang, Jun-Ho
Kantarjian, Hagop
Duan, Yinghui
Potluri, Jalaja
Werner, Michael
Pratz, Keith W.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E422 - E425
[7] Infections of Venetoclax-Based Chemotherapy in Acute Myeloid Leukemia: Rationale for Proper Antimicrobial Prophylaxis
Lee, Raeseok
Cho, Sung-Yeon
Lee, Dong-Gun
Choi, Hyeah
Park, Silvia
Cho, Byung-Sik
Kim, Yoo-Jin
Kim, Hee-Je
[J]. CANCERS, 2021, 13 (24)
[8] Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent
On, Sandy
Rath, Carolyn G.
Lan, Michelle
Wu, Bobby
Lau, Kimberly M.
Cheung, Edna
Alegria, William
Young, Rebecca
Tan, Marisela
Kim, Carrie
Phun, Jennifer
Patel, Nimish
Mannis, Gabriel
Logan, Aaron C.
Kennedy, Vanessa
Goodman, Aaron
Taplitz, Randy A.
Young, Patricia A.
Wen, Raymond
Saunders, Ila M.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (01) : 63 - 70
[9] Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia
Rausch, Caitlin R.
DiNardo, Courtney D.
Maiti, Abhishek
Jammal, Nadya J.
Kadia, Tapan M.
Marx, Kayleigh R.
Borthakur, Gautam
Savoy, J. Michael
Pemmaraju, Naveen
DiPippo, Adam J.
Daver, Naval G.
Chew, Serena M.
Sasaki, Koji
Issa, Ghayas C.
Short, Nicholas J.
Takahashi, Koichi
Ohanian, Maro N.
Ning, Jing
Xiao, Lianchun
Alvarado, Yesid
Kontoyiannis, Dimitrios P.
Ravandi, Farhad
Kantarjian, Hagop M.
Konopleva, Marina Y.
[J]. CANCER, 2021, 127 (14) : 2489 - 2499
[10] Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
Sciume, Mariarita
Bosi, Alessandro
Canzi, Marta
Ceparano, Giusy
Serpenti, Fabio
De Roberto, Pasquale
Fabris, Sonia
Tagliaferri, Elena
Cavallaro, Francesca
Onida, Francesco
Fracchiolla, Nicola Stefano
[J]. FRONTIERS IN ONCOLOGY, 2023, 13

← 1 2 →